| 1 | Nose Neoplasms | 37.9% |
| 2 | Laryngitis | 35.2% |
| 3 | Vocal Cord Dysfunction | 35.2% |
| 4 | Ear Neoplasms | 33.9% |
| 5 | Paranasal Sinus Neoplasms | 33.4% |
| 6 | Laryngeal Edema | 32.2% |
| 7 | Granuloma, Laryngeal | 31.9% |
| 8 | Laryngocele | 31.1% |
| 9 | Pharyngeal Neoplasms | 30.2% |
| 10 | Tracheal Neoplasms | 28.8% |
| 11 | Laryngostenosis | 27.9% |
| 12 | Maxillary Sinus Neoplasms | 27.4% |
| 13 | Laryngospasm | 25.8% |
| 14 | Nose Diseases | 25.1% |
| 15 | Voice Disorders | 24.9% |
| 16 | Voice Disturbance | 24.9% |
| 17 | Croup | 23.6% |
| 18 | Lung Neoplasms | 23.5% |
| 19 | Pleural Neoplasms | 23.5% |
| 20 | Laryngomalacia | 22.3% |
| 21 | Hypopharyngeal Neoplasms | 22.1% |
| 22 | Hypopharyngeal Cancer | 22.1% |
| 23 | Vocal Cord Paralysis | 22.1% |
| 24 | Nasopharyngeal Neoplasms | 21.7% |
| 25 | Rhinitis | 21.1% |
| 26 | Hoarseness | 19.9% |
| 27 | Pleural Effusion, Malignant | 19.8% |
| 28 | Bronchitis | 19.2% |
| 29 | Bronchial Neoplasms | 19.1% |
| 30 | Primary Ciliary Dyskinesia | 19% |
| 31 | Choanal Atresia | 18.7% |
| 32 | Tracheobronchomegaly | 18.7% |
| 33 | Pleuropneumonia | 18.3% |
| 34 | Tonsillar Neoplasms | 18.2% |
| 35 | Aphonia | 18.2% |
| 36 | Dysphonia | 18.2% |
| 37 | Bronchopneumonia | 17.3% |
| 38 | Sinusitis | 17.3% |
| 39 | Multiple Pulmonary Nodules | 17.3% |
| 40 | Asthma | 16.9% |
| 41 | Nasopharyngeal carcinoma | 16.8% |
| 42 | Bronchitis, Chronic | 16.6% |
| 43 | Granuloma, Lethal Midline | 16.1% |
| 44 | Nose Deformities, Acquired | 16.1% |
| 45 | Pleurisy | 16.1% |
| 46 | Pneumonia | 16.1% |
| 47 | Lobar Pneumonia | 16.1% |
| 48 | Respiratory Distress Syndrome, Adult | 16.1% |
| 49 | Tracheitis | 16.1% |
| 50 | Pneumonitis | 16.1% |
| 51 | Laryngopharyngeal Reflux | 15.8% |
| 52 | Bronchiolitis | 14.5% |
| 53 | Bronchial Diseases | 14.4% |
| 54 | Ear Diseases | 14.4% |
| 55 | Lung diseases | 14.4% |
| 56 | Pleural Diseases | 14.4% |
| 57 | Respiration Disorders | 14.4% |
| 58 | Thoracic Diseases | 14.4% |
| 59 | Tracheal Diseases | 14.4% |
| 60 | Lung Diseases, Fungal | 14.1% |
| 61 | Pharyngitis | 14.1% |
| 62 | Nasal Polyps | 14% |
| 63 | Respiratory Distress Syndrome, Newborn | 14% |
| 64 | Bronchial Fistula | 13.9% |
| 65 | Lung Abscess | 13.9% |
| 66 | Tuberculosis, Pulmonary | 13.9% |
| 67 | Rhinoscleroma | 13.7% |
| 68 | Acoustic Neuroma | 13.4% |
| 69 | Aspergillosis, Allergic Bronchopulmonary | 12.9% |
| 70 | Laryngeal Diseases | 12.6% |
| 71 | Pharyngeal Diseases | 12.6% |
| 72 | Epistaxis | 12.4% |
| 73 | Respiratory Tract Infections | 12.3% |
| 74 | Nasopharyngitis | 12.3% |
| 75 | Granuloma, Respiratory Tract | 12.2% |
| 76 | Respiratory Hypersensitivity | 12.2% |
| 77 | Respiratory Tract Fistula | 12.2% |
| 78 | Hay fever | 12% |
| 79 | Rhinitis, Allergic, Perennial | 12% |
| 80 | Kartagener Syndrome | 12% |
| 81 | Labyrinthitis | 11.8% |
| 82 | Aspiration Pneumonia | 11.8% |
| 83 | Rhinitis, Vasomotor | 11.8% |
| 84 | Parathyroid Neoplasms | 11.6% |
| 85 | Thyroid Neoplasm | 11.6% |
| 86 | Thyroid carcinoma | 11.6% |
| 87 | Laryngeal neoplasm | 11.2% |
| 88 | Idiopathic Pulmonary Fibrosis | 10.8% |
| 89 | Pneumoconiosis | 10.6% |
| 90 | Pneumonia, Viral | 10.6% |
| 91 | Mouth Neoplasms | 10.4% |
| 92 | Pneumonia, Bacterial | 10.4% |
| 93 | Tonsillitis | 10.3% |
| 94 | Hyaline Membrane Disease | 10.3% |
| 95 | Asthma, Exercise-Induced | 10.2% |
| 96 | Status Asthmaticus | 10.2% |
| 97 | Scimitar Syndrome | 10.1% |
| 98 | Acute Chest Syndrome | 9.9% |
| 99 | Meconium Aspiration Syndrome | 9.8% |
| 100 | Pneumonia, Lipid | 9.8% |
| 101 | Altitude Sickness | 9.4% |
| 102 | Atelectasis | 9.4% |
| 103 | Bronchospasm | 9.4% |
| 104 | Bronchiectasis | 9.4% |
| 105 | Chylothorax | 9.4% |
| 106 | Hydropneumothorax | 9.4% |
| 107 | Hydrothorax | 9.4% |
| 108 | Pulmonary Hypertension | 9.4% |
| 109 | Otosclerosis | 9.4% |
| 110 | Pneumothorax | 9.4% |
| 111 | Pulmonary Alveolar Proteinosis | 9.4% |
| 112 | Pulmonary Edema | 9.4% |
| 113 | Pulmonary Fibrosis | 9.4% |
| 114 | Respiratory Insufficiency | 9.4% |
| 115 | Tracheal Stenosis | 9.4% |
| 116 | Bronchial Hyperreactivity | 9.4% |
| 117 | Hamman-Rich syndrome | 9.4% |
| 118 | Lung Diseases, Interstitial | 9.4% |
| 119 | Respiratory Depression | 9.4% |
| 120 | Tympanosclerosis | 9.4% |
| 121 | Lung Diseases, Obstructive | 9.4% |
| 122 | Respiratory Failure | 9.4% |
| 123 | Asthma, Occupational | 9.3% |
| 124 | Bronchiolitis Obliterans | 9.2% |
| 125 | Esophageal Neoplasms | 9.2% |
| 126 | Radiation Pneumonitis | 9.2% |
| 127 | Radiation Fibrosis | 9.2% |
| 128 | Retropharyngeal Abscess | 9.1% |
| 129 | Abdominal Neoplasms | 8.8% |
| 130 | Soft Tissue Neoplasms | 8.8% |
| 131 | Thoracic Neoplasms | 8.8% |
| 132 | Asbestosis | 8.6% |
| 133 | Berylliosis | 8.6% |
| 134 | Silicosis | 8.6% |
| 135 | Mediastinal Cyst | 8.5% |
| 136 | Pericardial Cyst | 8.5% |
| 137 | Thymic Cyst | 8.5% |
| 138 | Farmer's Lung | 8.3% |
| 139 | Tympanic Membrane Perforation | 8.2% |
| 140 | Asthma, Aspirin-Induced | 8.2% |
| 141 | Otomycosis | 8% |
| 142 | Lung Injury | 8% |
| 143 | Hepatopulmonary Syndrome | 8% |
| 144 | Respiratory Aspiration | 8% |
| 145 | Congenital Microtia | 8% |
| 146 | Apnea | 8% |
| 147 | Cheyne-Stokes Respiration | 8% |
| 148 | Common Cold | 8% |
| 149 | Deglutition Disorders | 8% |
| 150 | Dyspnea | 8% |
| 151 | Hemothorax | 8% |
| 152 | Hyperventilation | 8% |
| 153 | Influenza | 8% |
| 154 | Mouth Breathing | 8% |
| 155 | Tachypnea | 8% |
| 156 | Catarrh | 8% |
| 157 | Pulmonary Embolism | 7.9% |
| 158 | Pulmonary Eosinophilia | 7.9% |
| 159 | Severe Acute Respiratory Syndrome | 7.9% |
| 160 | Eosinophilic Pneumonia | 7.9% |
| 161 | Digestive System Neoplasms | 7.7% |
| 162 | Endocrine Gland Neoplasms | 7.7% |
| 163 | Eye Neoplasms | 7.7% |
| 164 | Nervous System Neoplasms | 7.7% |
| 165 | Thyroid Nodule | 7.5% |
| 166 | Bone neoplasms | 7.5% |
| 167 | Skin Neoplasms | 7.5% |
| 168 | Hematologic Neoplasms | 7.5% |
| 169 | Peritonsillar Abscess | 7.5% |
| 170 | Splenic Neoplasms | 7.5% |
| 171 | Blastomycosis | 7.4% |
| 172 | Peritoneal Neoplasms | 6.9% |
| 173 | Airway Obstruction | 6.9% |
| 174 | Choking | 6.9% |
| 175 | Cochlear Diseases | 6.9% |
| 176 | Epiglottitis | 6.9% |
| 177 | Chronic Obstructive Airway Disease | 6.9% |
| 178 | Mediastinitis | 6.9% |
| 179 | Middle Lobe Syndrome | 6.9% |
| 180 | Otitis Externa | 6.9% |
| 181 | Otitis Media | 6.9% |
| 182 | Vestibular Diseases | 6.9% |
| 183 | Endolymphatic Hydrops | 6.9% |
| 184 | Acute Lung Injury | 6.9% |
| 185 | Hemoptysis | 6.9% |
| 186 | Pertussis | 6.9% |
| 187 | Dysacusis | 6.9% |
| 188 | Multiple Endocrine Neoplasia | 6.6% |
| 189 | Leukoplakia, Oral | 6.4% |
| 190 | Cystic Fibrosis | 6.3% |
| 191 | Pancreatic Neoplasm | 6.3% |
| 192 | Paraneoplastic Encephalomyelitis | 6.1% |
| 193 | Herpes Zoster Oticus | 6.1% |
| 194 | Eyelid Neoplasms | 6.1% |
| 195 | Mammary Neoplasms, Experimental | 6% |
| 196 | Salivary Gland Neoplasms | 6% |
| 197 | Tongue Neoplasms | 6% |
| 198 | Vestibulocochlear Nerve Diseases | 6% |
| 199 | Persistent Fetal Circulation Syndrome | 6% |
| 200 | Histiocytosis, Langerhans-Cell | 5.9% |
| 201 | Mediastinal Emphysema | 5.9% |
| 202 | Pulmonary Aspergillosis | 5.9% |
| 203 | Bronchopulmonary Aspergillosis | 5.9% |
| 204 | Hypoventilation | 5.9% |
| 205 | Acidosis, Respiratory | 5.9% |
| 206 | Alkalosis, Respiratory | 5.9% |
| 207 | Sarcoidosis, Pulmonary | 5.9% |
| 208 | Sleep Apnea Syndromes | 5.9% |
| 209 | Pulmonary Infarction | 5.9% |
| 210 | Meniere Disease | 5.7% |
| 211 | Otitis Media with Effusion | 5.7% |
| 212 | Pulmonary Emphysema | 5.7% |
| 213 | Palatal Neoplasms | 5.7% |
| 214 | Acanthoma | 5.4% |
| 215 | Hamartoma | 5.4% |
| 216 | Neoplasms, Hormone-Dependent | 5.4% |
| 217 | Neoplasms, Multiple Primary | 5.4% |
| 218 | Paraneoplastic Syndromes | 5.4% |
| 219 | Precancerous Conditions | 5.4% |
| 220 | Neoplasms, Second Primary | 5.4% |
| 221 | Retroperitoneal Neoplasms | 5.2% |
| 222 | Dyspnea, Paroxysmal | 5.1% |
| 223 | Respiratory Paralysis | 5.1% |
| 224 | Granulomatosis with polyangiitis | 5.1% |
| 225 | Hyperacusis | 5.1% |
| 226 | Tinnitus | 5.1% |
| 227 | Phonophobia | 5.1% |
| 228 | Hearing Loss | 5.1% |
| 229 | Lemierre Syndrome | 4.9% |
| 230 | Bronchopulmonary Dysplasia | 4.9% |
| 231 | Vestibular Neuronitis | 4.9% |
| 232 | Sleep Apnea, Obstructive | 4.9% |
| 233 | Sleep Apnea, Central | 4.9% |
| 234 | Carcinoma, Lobular | 4.7% |
| 235 | Testicular Neoplasms | 4.7% |
| 236 | Cyst | 4.6% |
| 237 | Neoplastic Processes | 4.6% |
| 238 | Neoplastic Syndromes, Hereditary | 4.6% |
| 239 | Pregnancy Complications, Neoplastic | 4.6% |
| 240 | Neoplasms, Experimental | 4.6% |
| 241 | Anti-Glomerular Basement Membrane Disease | 4.5% |
| 242 | Bronchomalacia | 4.5% |
| 243 | Tracheomalacia | 4.5% |
| 244 | Central Nervous System Neoplasms | 4.5% |
| 245 | Vascular Neoplasms | 4.5% |
| 246 | Thymus Neoplasms | 4.5% |
| 247 | Genital Neoplasms, Female | 4.4% |
| 248 | Breast Neoplasms, Male | 4.4% |
| 249 | Triple Negative Breast Neoplasms | 4.4% |
| 250 | Vertigo | 4.3% |
| 251 | Transfusion-Related Acute Lung Injury | 4.3% |
| 252 | Invasive Pulmonary Aspergillosis | 4.3% |
| 253 | Mastoiditis | 4.2% |
| 254 | Petrositis | 4.2% |
| 255 | Deafness | 4.2% |
| 256 | Hearing Loss, Sudden | 4.2% |
| 257 | Hearing Loss, Bilateral | 4.2% |
| 258 | Hearing Loss, High-Frequency | 4.2% |
| 259 | Hearing Loss, Mixed Conductive-Sensorineural | 4.2% |
| 260 | Hearing Loss, Unilateral | 4.2% |
| 261 | Complete Hearing Loss | 4.2% |
| 262 | Deaf Mutism | 4.2% |
| 263 | Carcinoma, Pancreatic Ductal | 4.1% |
| 264 | Multiple Endocrine Neoplasia Type 1 | 4.1% |
| 265 | Neoplasms, Radiation-Induced | 4% |
| 266 | Meningioma | 4% |
| 267 | Adrenal Gland Neoplasms | 3.9% |
| 268 | Gastrointestinal Neoplasms | 3.9% |
| 269 | Genital Neoplasms, Male | 3.9% |
| 270 | Liver neoplasms | 3.9% |
| 271 | Uveal Neoplasms | 3.9% |
| 272 | Parotid Neoplasms | 3.9% |
| 273 | Urologic Neoplasms | 3.9% |
| 274 | Sebaceous Gland Neoplasms | 3.9% |
| 275 | Spinal Neoplasms | 3.9% |
| 276 | Bone Marrow Neoplasms | 3.9% |
| 277 | Thymoma | 3.8% |
| 278 | Liver Neoplasms, Experimental | 3.8% |
| 279 | Tuberous Sclerosis | 3.7% |
| 280 | Carcinoma 256, Walker | 3.6% |
| 281 | Carcinoma, Ehrlich Tumor | 3.5% |
| 282 | Dermoid Cyst | 3.5% |
| 283 | Carcinoma, Lewis Lung | 3.5% |
| 284 | Trophoblastic Neoplasms | 3.5% |
| 285 | Leukemia, Experimental | 3.4% |
| 286 | Eosinophilic Granuloma | 3.4% |
| 287 | Paraneoplastic Cerebellar Degeneration | 3.4% |
| 288 | Nephroblastoma | 3.2% |
| 289 | Melanoma, Experimental | 3.2% |
| 290 | Pituitary Adenoma | 3.2% |
| 291 | Pituitary Neoplasms | 3.2% |
| 292 | insulinoma | 3.2% |
| 293 | Vipoma | 3.2% |
| 294 | Gastrinoma | 3.1% |
| 295 | Glucagonoma | 3.1% |
| 296 | Retinoblastoma | 3.1% |
| 297 | Leukemia, Radiation-Induced | 3.1% |
| 298 | ovarian neoplasm | 3.1% |
| 299 | Auditory Perceptual Disorders | 3.1% |
| 300 | Limbic Encephalitis | 3% |
| 301 | Hepatocellular Adenoma | 3% |
| 302 | Sarcoma, Experimental | 3% |
| 303 | Neoplasms, Neuroepithelial | 3% |
| 304 | Gliomatosis cerebri | 3% |
| 305 | Neuroectodermal Tumors | 3% |
| 306 | Meningeal Neoplasms | 2.9% |
| 307 | Erythroplasia | 2.9% |
| 308 | Follicular cyst | 2.9% |
| 309 | leukemia | 2.9% |
| 310 | Mucocele | 2.9% |
| 311 | Neoplasms, Germ Cell and Embryonal | 2.9% |
| 312 | Neoplasms, Glandular and Epithelial | 2.9% |
| 313 | Pilonidal Cyst | 2.9% |
| 314 | Thyroglossal Cyst | 2.9% |
| 315 | Synovial Cyst | 2.9% |
| 316 | Germ Cell Cancer | 2.9% |
| 317 | Aberrant Crypt Foci | 2.9% |
| 318 | Lambert-Eaton Myasthenic Syndrome | 2.8% |
| 319 | Prolactinoma | 2.7% |
| 320 | Growth Hormone-Secreting Pituitary Adenoma | 2.7% |
| 321 | Optic Nerve Glioma | 2.7% |
| 322 | Leydig Cell Tumor | 2.7% |
| 323 | Brain Neoplasms | 2.6% |
| 324 | Spinal Cord Neoplasms | 2.6% |
| 325 | Opsoclonus-Myoclonus Syndrome | 2.5% |
| 326 | melanoma | 2.5% |
| 327 | Uterine Neoplasms | 2.5% |
| 328 | Vaginal Neoplasms | 2.5% |
| 329 | Vulvar Neoplasms | 2.5% |
| 330 | Uterine Cancer | 2.5% |
| 331 | Fallopian Tube Neoplasms | 2.5% |
| 332 | Leukoplakia | 2.5% |
| 333 | Lymphocele | 2.5% |
| 334 | Pancreatic Cyst | 2.5% |
| 335 | Barrett Esophagus | 2.5% |
| 336 | Breast Cyst | 2.5% |
| 337 | Histiocytic Disorders, Malignant | 2.5% |
| 338 | Actinic keratosis | 2.5% |
| 339 | Neoplasm Invasiveness | 2.5% |
| 340 | Neoplasm Metastasis | 2.5% |
| 341 | Neoplasm Recurrence, Local | 2.5% |
| 342 | Parovarian Cyst | 2.5% |
| 343 | Carcinogenesis | 2.5% |
| 344 | Myxoid cyst | 2.5% |
| 345 | Metastasis | 2.5% |
| 346 | Carcinosarcoma | 2.5% |
| 347 | Hemangiosarcoma | 2.5% |
| 348 | Leukemia L1210 | 2.5% |
| 349 | Leukemia P388 | 2.5% |
| 350 | lymphangiosarcoma | 2.5% |
| 351 | Lymphomatoid Granulomatosis | 2.4% |
| 352 | Choriocarcinoma | 2.4% |
| 353 | Adenomatous Polyposis Coli | 2.4% |
| 354 | granulosa cell tumor | 2.4% |
| 355 | Carcinoma, Ovarian Epithelial | 2.4% |
| 356 | Medulloblastoma | 2.4% |
| 357 | Myelitis, Transverse | 2.3% |
| 358 | Central Nervous System Cysts | 2.3% |
| 359 | Mesoblastic Nephroma | 2.3% |
| 360 | Basal Cell Nevus Syndrome | 2.3% |
| 361 | Bile Duct Neoplasms | 2.3% |
| 362 | gallbladder neoplasm | 2.3% |
| 363 | Intestinal Neoplasms | 2.3% |
| 364 | Penile Neoplasms | 2.3% |
| 365 | Prostatic Neoplasms | 2.3% |
| 366 | Stomach Neoplasms | 2.3% |
| 367 | Composite Lymphoma | 2.3% |
| 368 | Polycythemia Vera | 2.2% |
| 369 | Sarcoma 180 | 2.2% |
| 370 | Meningeal Carcinomatosis | 2.2% |
| 371 | Lymphoma | 2.2% |
| 372 | Corpus Luteum Cyst | 2.2% |
| 373 | Ovarian Cysts | 2.2% |
| 374 | Leukemia, Plasma Cell | 2.1% |
| 375 | Adenoma, Acidophil | 2.1% |
| 376 | Ganglioneuroma | 2.1% |
| 377 | Glioma | 2.1% |
| 378 | Malignant Glioma | 2.1% |
| 379 | Bladder Neoplasm | 2% |
| 380 | Kidney Neoplasm | 2% |
| 381 | Ureteral Neoplasms | 2% |
| 382 | Urethral Neoplasms | 2% |
| 383 | Adrenocortical carcinoma | 2% |
| 384 | Basal cell carcinoma | 2% |
| 385 | Carcinoma, Papillary | 2% |
| 386 | Squamous cell carcinoma | 2% |
| 387 | Chondrosarcoma | 2% |
| 388 | Craniopharyngioma | 2% |
| 389 | Cystadenoma | 2% |
| 390 | leiomyosarcoma | 2% |
| 391 | liposarcoma | 2% |
| 392 | Mesothelioma | 2% |
| 393 | synovial sarcoma | 2% |
| 394 | Neuroectodermal Tumor, Melanotic | 2% |
| 395 | Angiomyolipoma | 2% |
| 396 | Clear Cell Sarcoma of Soft Tissue | 2% |
| 397 | Alveolar Soft Part Sarcoma | 2% |
| 398 | Neuroendocrine Tumors | 2% |
| 399 | Sarcoma, Myeloid | 2% |
| 400 | Carcinoma, Basal Cell | 2% |
| 401 | Choledochal Cyst | 1.9% |
| 402 | Supratentorial Neoplasms | 1.9% |
| 403 | Peutz-Jeghers Syndrome | 1.9% |
| 404 | Carcinoid Tumor | 1.9% |
| 405 | Endometrial Neoplasms | 1.9% |
| 406 | Neurilemmoma | 1.9% |
| 407 | Hutchinson's Melanotic Freckle | 1.9% |
| 408 | Melanoma, Amelanotic | 1.9% |
| 409 | Renal Cell Carcinoma | 1.8% |
| 410 | Papillary Renal Cell Carcinoma | 1.8% |
| 411 | Adenoma | 1.7% |
| 412 | Ameloblastoma | 1.7% |
| 413 | Angiokeratoma | 1.7% |
| 414 | Carcinoma | 1.7% |
| 415 | Chordoma | 1.7% |
| 416 | Hemangioma | 1.7% |
| 417 | hemangiopericytoma | 1.7% |
| 418 | Lymphangioma | 1.7% |
| 419 | Mesenchymoma | 1.7% |
| 420 | Nevus | 1.7% |
| 421 | Teratoma | 1.7% |
| 422 | Hepatoblastoma | 1.7% |
| 423 | Mixed Tumor, Mullerian | 1.7% |
| 424 | Germinoma | 1.7% |
| 425 | Teratocarcinoma | 1.7% |
| 426 | Angiofibroma | 1.7% |
| 427 | Sarcoma | 1.7% |
| 428 | Epithelioma | 1.7% |
| 429 | Cystadenocarcinoma | 1.7% |
| 430 | Fibrosarcoma | 1.7% |
| 431 | Osteosarcoma | 1.7% |
| 432 | Mucoepidermoid Carcinoma | 1.7% |
| 433 | Denys-Drash Syndrome | 1.7% |
| 434 | Prostatic Neoplasms, Castration-Resistant | 1.7% |
| 435 | Astrocytoma | 1.7% |
| 436 | Ependymoma | 1.7% |
| 437 | oligodendroglioma | 1.7% |
| 438 | Ganglioglioma | 1.7% |
| 439 | gliosarcoma | 1.7% |
| 440 | Anaplastic astrocytoma | 1.7% |
| 441 | Anaplastic Oligodendroglioma | 1.7% |
| 442 | Endometrial Stromal Sarcoma | 1.7% |
| 443 | Nelson Syndrome | 1.7% |
| 444 | Carcinoma, Endometrioid | 1.6% |
| 445 | Adenofibroma | 1.6% |
| 446 | Fibroadenoma | 1.6% |
| 447 | Malignant Fibrous Histiocytoma | 1.6% |
| 448 | Brain Stem Neoplasms | 1.6% |
| 449 | Malignant Carcinoid Syndrome | 1.6% |
| 450 | Cecal Neoplasms | 1.5% |
| 451 | Duodenal Neoplasms | 1.5% |
| 452 | Lymphangioleiomyomatosis | 1.5% |
| 453 | Pancreatic Pseudocyst | 1.5% |
| 454 | Plasmacytoma | 1.5% |
| 455 | Hydatidiform Mole | 1.5% |
| 456 | Malignant histiocytosis | 1.5% |
| 457 | Lymphatic Metastasis | 1.5% |
| 458 | Neoplasms, Unknown Primary | 1.5% |
| 459 | Leukemic Infiltration | 1.5% |
| 460 | Histiocytic sarcoma | 1.5% |
| 461 | Neoplasm Micrometastasis | 1.5% |
| 462 | Glioblastoma | 1.5% |
| 463 | Neuroblastoma | 1.5% |
| 464 | Glioblastoma Multiforme | 1.5% |
| 465 | Bowen's Disease | 1.5% |
| 466 | Paraganglioma | 1.5% |
| 467 | Rhabdomyosarcoma | 1.5% |
| 468 | Giant Cell Tumor of Bone | 1.5% |
| 469 | Choroid Plexus Papilloma | 1.4% |
| 470 | Neurofibrosarcoma | 1.4% |
| 471 | Cerebellar Neoplasms | 1.4% |
| 472 | Colorectal Neoplasms | 1.4% |
| 473 | Ganglioneuroblastoma | 1.4% |
| 474 | Dermatofibrosarcoma | 1.3% |
| 475 | Dermatofibrosarcoma Protuberans | 1.3% |
| 476 | Xeroderma Pigmentosum | 1.3% |
| 477 | Hodgkin Disease | 1.3% |
| 478 | Lymphoma, Non-Hodgkin | 1.3% |
| 479 | Polycystic Ovary Syndrome | 1.3% |
| 480 | Carcinoid Heart Disease | 1.3% |
| 481 | Appendiceal Neoplasms | 1.2% |
| 482 | Colonic Neoplasms | 1.2% |
| 483 | Rectal Neoplasms | 1.2% |
| 484 | Pheochromocytoma | 1.2% |
| 485 | Alveolar rhabdomyosarcoma | 1.2% |
| 486 | Adenocarcinoma | 1.1% |
| 487 | Carcinoma in Situ | 1.1% |
| 488 | Carcinoma, Transitional Cell | 1.1% |
| 489 | Phyllodes Tumor | 1.1% |
| 490 | Dysgerminoma | 1.1% |
| 491 | Hemangioendothelioma | 1.1% |
| 492 | Lipoma | 1.1% |
| 493 | Myoma | 1.1% |
| 494 | Myxoma | 1.1% |
| 495 | Neuroma | 1.1% |
| 496 | Papilloma | 1.1% |
| 497 | Pseudomyxoma Peritonei | 1.1% |
| 498 | Seminoma | 1.1% |
| 499 | Papillomatosis | 1.1% |
| 500 | Angiolipoma | 1.1% |
| 501 | Myelolipoma | 1.1% |
| 502 | Neoplasms, Bone Tissue | 1.1% |
| 503 | Neoplasms, Fibrous Tissue | 1.1% |
| 504 | Smooth Muscle Tumor | 1.1% |
| 505 | Adenomatosis, Pulmonary | 1.1% |
| 506 | Adenomatous Polyps | 1.1% |
| 507 | Carcinoma, Large Cell | 1.1% |
| 508 | Carcinoma, Small Cell | 1.1% |
| 509 | Desmoplastic Small Round Cell Tumor | 1.1% |
| 510 | Chondroma | 1.1% |
| 511 | Enchondroma | 1.1% |
| 512 | Primary amyloidosis | 1.1% |
| 513 | Anus Neoplasms | 1% |
| 514 | Sigmoid Neoplasms | 1% |
| 515 | Leukemia, Myelomonocytic, Chronic | 1% |
| 516 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 1% |
| 517 | Waldenstrom Macroglobulinemia | 0.9% |
| 518 | Multiple Myeloma | 0.9% |
| 519 | Mastocytosis | 0.9% |
| 520 | Sturge-Weber Syndrome | 0.9% |
| 521 | Adenoid Cystic Carcinoma | 0.9% |
| 522 | fibroma | 0.9% |
| 523 | Fibromatosis | 0.9% |
| 524 | Osteoblastoma | 0.9% |
| 525 | Osteoma | 0.9% |
| 526 | Rhabdomyoma | 0.9% |
| 527 | Chondromatosis | 0.9% |
| 528 | Adenocarcinoma, Clear Cell | 0.9% |
| 529 | Cholangiocarcinoma | 0.9% |
| 530 | Cervical Intraepithelial Neoplasia | 0.9% |
| 531 | Hemangioblastoma | 0.9% |
| 532 | Lymphoma, Extranodal NK-T-Cell | 0.9% |
| 533 | Cell Transformation, Viral | 0.9% |
| 534 | Gastrointestinal Stromal Tumors | 0.9% |
| 535 | Hemangioma, Cavernous | 0.9% |
| 536 | Leukemia, T-Cell | 0.8% |
| 537 | Leukemia, B-Cell | 0.8% |
| 538 | neurofibroma | 0.8% |
| 539 | Lymphoma, Follicular | 0.8% |
| 540 | Zollinger-Ellison syndrome | 0.8% |
| 541 | T-Cell Lymphoma | 0.8% |
| 542 | Mantle cell lymphoma | 0.8% |
| 543 | Mastocytoma | 0.7% |
| 544 | Mastocytosis, Systemic | 0.7% |
| 545 | Leukemia, Myeloid, Chronic-Phase | 0.7% |
| 546 | Fibromatosis, Aggressive | 0.7% |
| 547 | Fibromatosis, Abdominal | 0.7% |
| 548 | Klatskin Tumor | 0.7% |
| 549 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.6% |
| 550 | Leukemia, Large Granular Lymphocytic | 0.6% |
| 551 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.6% |
| 552 | Lymphoma, T-Cell, Cutaneous | 0.6% |
| 553 | Lymphoma, AIDS-Related | 0.6% |
| 554 | Enteropathy-Associated T-Cell Lymphoma | 0.6% |
| 555 | Primary Effusion Lymphoma | 0.6% |
| 556 | Dupuytren Contracture | 0.5% |
| 557 | Urticaria Pigmentosa | 0.5% |
| 558 | Mycosis Fungoides | 0.5% |
| 559 | Lymphomatoid Papulosis | 0.5% |
| 560 | Plasmablastic lymphoma | 0.5% |
| 561 | Burkitt Lymphoma | 0.5% |
| 562 | Sezary Syndrome | 0.4% |
| 563 | Radicular Cyst | 0.4% |